Developing new treatments for Alzheimer's disease: the who, what, when, and how of biomarker-guided therapies

E-ISSN： 1741-203x|20|5|871-889

ISSN： 1041-6102

Source： International Psychogeriatrics, Vol.20, Iss.5, 2008-10, pp. : 871-889

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Who, What, When, Where, How, and Mostly Why? A Therapist's Grief Over the Suicide of a Client

By Anderson Gail O.

Women & Therapy, Vol. 28, Iss. 1, 2004-12 ,pp. : 25-34

Haworth Press

Access to resources Recommend Favorite

Developing medicines for agitation and aggression in Alzheimer's disease

International Psychogeriatrics, Vol. 27, Iss. 2, 2014-12 ,pp. : 179-179

Cambridge University Press

Access to resources Recommend Favorite

Group and individual cognitive therapies in Alzheimer's disease: the ETNA3 randomized trial

International Psychogeriatrics, Vol. 28, Iss. 5, 2016-05 ,pp. : 707-717

Cambridge University Press

Access to resources Recommend Favorite

Understanding Former Smokers in Canada: Examining Who They are and When, Why and How They Quit

Journal of Smoking Cessation, Vol. 4, Iss. 2, 2009-12 ,pp. : 79-85

Cambridge University Press

Access to resources Recommend Favorite

Pray Tell: The Who, What, Why, and How of Prayer Across Multiple Faiths

By Silton Nava

Pastoral Psychology, Vol. 62, Iss. 1, 2013-02 ,pp. : 41-52

Springer Publishing Company

Access to resources Recommend Favorite